Increase of precuneus metabolism correlates with reduction of PTSD symptoms after EMDR therapy in military veterans: an 18F-FDG PET study during virtual reality exposure to war by Rousseau, P., et al.
HAL Id: hal-02479693
https://hal.archives-ouvertes.fr/hal-02479693
Submitted on 6 Apr 2020
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Increase of precuneus metabolism correlates with
reduction of PTSD symptoms after EMDR therapy in
military veterans: an 18F-FDG PET study during
virtual reality exposure to war
P. Rousseau, E. Malbos, A. Verger, F. Nicolas, C. Lançon, S. Khalfa, Eric
Guedj
To cite this version:
P. Rousseau, E. Malbos, A. Verger, F. Nicolas, C. Lançon, et al.. Increase of precuneus metabolism
correlates with reduction of PTSD symptoms after EMDR therapy in military veterans: an 18F-
FDG PET study during virtual reality exposure to war. European Journal of Nuclear Medicine and
Molecular Imaging, Springer Verlag (Germany), 2019, 46 (9), pp.1817-1821. ￿10.1007/s00259-019-
04360-1￿. ￿hal-02479693￿
Responses to Reviewers 
 
Reviewers' comments: 
 
Reviewer #1: Comments to Editor 
The manuscript "Increase of precuneus metabolism correlates with reduction of PTSD 
symptoms after EMDR therapy in military veterans: an 18F-FDG PET study during virtual 
reality exposure to war" by Rousseau et al deals with very actual topic: the disclosure of the 
neurobiology of psychotherapies. Furthermore, approaching such matter by PET activation 
studies, after about 30 years since the first 15O-H2O ones, using FDG might start a new 
season for this fascinating research field 
 
The manuscript is concise, well written and pretty clear in the aims, methods, results and 
discussion and in my opinion misses only a few information that will would improve its 
quality. 
 
I have a general comment and some minor specific remarks 
 
General comments 
The authors have recently published on the EJNMMI an editorial promoting functional 18F-
FDG PET brain activation imaging. A similar study to the present one was published on the 
same Journal in 2015 (Eur J Nucl Med Mol Imaging (2015) 42:733-740) in which the very 
same protocol and methodology were used with the only difference that the stressing stimulus 
was olfactory and not visual. 
Since the readers of the present paper will be (firstly) nuclear medicine physicians it is 
opinion of this reviewer that the above paper should be quoted and the methodology 
implemented in both of them better "promoted" in the introduction and discussion to stimulate 
the colleagues to perform similar studies. 
 
It is also the opinion of this reviewer that it is a pity that the authors decided to submit such 
interesting and ground-breaking paper as short communication instead of full paper. 
 
Reply: Thanks to the Reviewer for his/her highly positive comments. As mentioned, we are 
limited by the constraints of a short communication that we indeed chose considering this 
work as a pilot study with the inclusion of only fifteen subjects. At the discretion of the 
Editor, the paper could possibly be considered for an Editorial to highlight the original points 
raised by the Reviewer. Nevertheless, the text has been reasonably lengthened on this revision 
to better include these aspects. In details, the use of 18F-FDG brain PET imaging for activation 
studies has now been promoted in regard to our recent published articles (ref 5 and 7), but 
also the interesting recommended reference proposed by the Reviewer (ref 6), in the 
Introduction (p3, l19-22 Indeed, the use of 18F-FDG brain PET imaging for activation 
studies has been recently proposed to investigate brain metabolic changes during stimuli 
tasks such as olfactory stimulations or VRE tasks Discussion (p7, l6-12): 
Therefore, this study highlights the exciting opportunity to use PET imaging to investigate 
brain metabolism during virtual exposure, and provides additional information on the 
pathophysiological response of EMDR therapy on PTSD. In comparison to functional 
magnetic resonance imaging (fMRI), the competitive advantage of 18F-FDG brain PET 
imaging is to possibly capture an activation paradigm outside the acquisition scanner, during 
the radiopharmaceutical injection, and thus possibly develop complex paradigms involving 
for example VRE. In this line, this approach could be extended to other virtual environments 
or neuropsychological conditions.  
 
 
Minor remarks 
In the Introduction line 19-20 it should be made clear that the study quoted in reference 4 was 
performed by EEG, not fMRI. 
Reply: This has been modified accordingly in the Introduction (p3, l12- Previous studies 
showed functional changes in structures involved in the fear network using fMRI (3) and EEG 
(4) on activation tasks after EMDR.  
 
At page 5, first paragraph the authors should be more precise about the chosen statistical 
threshold (p valure corrected/not corrected for multiple comparisons; in case FDR o FWE 
corrected?). The choice of cluster volume is not a correction, is a size threshold. 
Reply: Thanks for this remark. The statistical threshold was p<0.005 uncorrected, with a k 
size threshold >180. This choice has been made to limit type-II errors.  
It has been modified accordingly throughout the manuscript.  
 
At page 7, lines 22-25 the authors speculate about precuneus and DMN. I would not go into 
such discussion since the DMN is active at rest and in the present case its increased 
metabolism is found during emotional activation. 
Reply: We agree with the Reviewer. We have modified this sentence by deleting the term 
DMN in the Discussion (p7, l21- Due to its functions, we can assume that the precuneus 
can modulate the subjective experience of anxious and fearful states to reprocess the 
traumatic memory and discharge it from its emotional load  
 
 
Reviewer #2: Straightforward report of small study of PTSD patients scanned with FDG-PET 
before and after EMDR treatment. Clearly described and interpreted with due care and 
caution regarding the small sample. 
Reply: Thanks to the Reviewer for his/her positive comments. 
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Abstract 
 
Purpose: The prevalence of posttraumatic stress disorder (PTSD) is higher among veterans and 
can lead to disastrous consequences such as suicide. Eye Movement Desensitization and 
Reprocessing (EMDR) is recommended in first-line psychotherapies for PTSD. Virtual reality 
exposure (VRE) coupled with 18F-FDG PET imaging can highlight the activated brain regions 
during stress exposure. The objective of this study is to identify, after EMDR therapy, the 
regions of brain metabolism that evolve during the stress exposure of a war scene with 
symptomatic remission in a group of military veterans suffering from PTSD and to secondarily 
search for predictive metabolic features. 
Methods: We recruited fifteen military veterans suffering from PTSD who performed an 18F-
FDG PET sensitized by the exposure to a virtual war scene, before (T0) and after (T1) EMDR 
therapy. Statistical parametric mapping was used to compare brain metabolism before and after 
treatment and to study correlations between metabolism and evolution scores on PTSD clinical 
scales (PTSD Checklist Scale, PCLS; Clinician Administered PTSD Scale, CAPS). 
Results: The metabolic activity of the precuneus was increased after EMDR therapy (p<0.005 
uncorrected, k>180) and correlated with clinical improvement with the CAPS scale (r=-0.73 
and p<0.001). Moreover, the precuneus metabolic value before therapy predicted the clinical 
improvement on the PCLS scale (T1-T0) after EMDR (r=-0.667 and p<0.006). 
Conclusion: The clinical improvement in military patients with PTSD after EMDR is related 
to increased precuneus metabolism upon VR stress exposure. 
 
Keywords 
Posttraumatic Stress Disorder; Brain Metabolism; PET; Eye Movement Desensitization and 
Reprocessing; Virtual Reality Exposure; War; Veterans 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
Introduction 
Posttraumatic stress disorder (PTSD) is a condition that can develop following an exposure to 
traumatic events. The rates of PTSD in veterans are higher than in the civilian population, at 
close to 35% of Army and Marine troops having PTSD after deployment (1). 
The pathophysiology of PTSD has been studied with neuroimaging and paradigms such as 
script-driven imagery and visual emotional stimuli, demonstrating brain abnormalities in the 
fear network, in the reward and motivation network, and in the default mode network (2). 
Eye Movement Desensitization and Reprocessing (EMDR) therapy is recommended in first-
line psychotherapies for PTSD. EMDR includes associations of cognitive, emotional and 
physical assessments of actual distress to the traumatic scenery during bilateral alternating 
stimulations (auditory, visual, tactile stimuli alternating between the two sides of the body). 
Previous studies showed functional changes in structures involved in the fear network using 
fMRI (3) and EEG (4) on activation tasks after EMDR. 
Displaying more ecological environments is now possible with virtual reality exposure (VRE), 
which allows patients to be immersed in a computer-generated virtual environment mimicking 
real-life in laboratory conditions. VRE provides the unique opportunity to study 
pathophysiological changes in an ecologically relevant setting during simulated trauma event 
exposure. Interestingly, VRE can also be associated with 18F-FDG PET imaging to measure 
brain metabolism during confrontation with the traumatic event (5). Indeed, the use of 18F-FDG 
brain PET imaging for activation studies has been recently proposed to investigate brain 
metabolic changes during stimuli tasks such as olfactory stimulations (6) or VRE tasks (7).  
The objective of this study is to identify, after EMDR therapy, the regions of brain metabolism 
that evolve during stress exposure to a war scene with symptomatic remission in a group of 
military veterans suffering from PTSD and to secondarily search for predictive metabolic 
features.  
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Materials and Methods 
Participants 
Military PTSD patients were recruited in the military hospital Sainte-Anne at Toulon, France. 
Diagnosis of PTSD was established according to the DSM-IV TR (8). We excluded patients 
with present and/or past neurological or psychiatric conditions, with the exception of anxiety 
and depressive disorders if their occurrence was connected with PTSD. Patients with an 
addictive disorder, even in relation to PTSD, were excluded. We used the Posttraumatic Stress 
Checklist Scale (PCLS) (9), which is a brief and self-report questionnaire for evaluating the 
severity of the three main syndromes of PTSD, and the Clinician-Administered PTSD Scale 
(CAPS) (10), which is a structured interview providing a categorical diagnosis, as well as a 
measure of the severity of PTSD symptoms as defined by the DSM. 
All the soldiers included had PTSD related to war combat (Afghanistan and Mali). None had 
received formal exposure or cognitive-behavioural therapy before the EMDR procedure. Socio-
demographic characteristics, including comorbidity, medications, and duration of illness, are 
described in Table 1. 
 
EMDR procedure 
EMDR therapy was performed according to the standard protocol. Sessions were planned every 
7 to 15 days according to the availability of patients and therapists. Patients could receive a 
maximum of eight EMDR sessions depending on their clinical course. All patients were 
symptom-free and no longer diagnosed with PTSD after EMDR therapy, as assessed by a 
psychiatrist diagnosis according to DSM-IV criteria and clinical PTSD scales. 
 
18F-FDG-PET Acquisition and Analysis 
18F-FDG PET was performed using an integrated PET/CT camera (Discovery 710, GE 
Healthcare, Waukeskha, WI) with parameters previously described (7). Each subject was 
confronted with intense trauma cues, consisting of the attack on their group by insurgents during 
a patrol in an artificially created village in Afghanistan, with several virtual soldiers wounded, 
(screen captures in Figure 1). Patients were exposed to the environment approximately 10 min 
before the injection. 18F-FDG (150 MBq) was injected intravenously one minute before their 
unit was assaulted, and the virtual exposure immersion was maintained after injection for 
approximately 7 min. Thereafter, patients were placed in a quiet environment with their eyes 
closed but continued to feel the stress of the VRE. PET images, acquired in a lying position as 
recommended in standard practice, started 30 min after the injection and ended 15 min later. 
Finally, patients were asked to indicate the fear felt during the VRE. The degree of fear was 
measured by an SUD for subjective units of discomfort ranging from 0 (no disturbance) to 10 
(maximum disturbance) as previously described (7). 
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Whole-brain statistical analysis was performed at the voxel level using SPM8 software 
(Wellcome Department of Cognitive Neurology, University College, London, UK) as 
previously reported (7). SPM (T) maps were generated for comparison before and after EMDR 
therapy using paired t-tests (p<0.005 uncorrected, k>180). Mean values of metabolism were 
extracted at the individual level for significant cluster(s) to calculate correlations with clinical 
scores (PCLS and CAPS scores at T0 (before therapy), T1 (after therapy) and T1-T0). 
 
Statistical analysis 
Spearman correlations were performed between the PCLS and CAPS scores at T0, T1, for T1-
T0 and the metabolism of significant cluster(s) extracted from the paired-SPM analysis 
performed before and after EMDR and their related changes. We applied a Bonferroni 
correction (k=8 and p<0.00625). Scores on clinical scales have been compared by paired t-tests. 
A p-value <0.05 was considered significant.  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
Results 
 
Patients and changes in PET metabolism after EMDR therapy 
The EMDR group was composed of seventeen military participants (mean age 36.8 ±5.9 years). 
Of all patients enrolled, two were excluded from the analyses, one having not completed EMDR 
therapy and the other not being able to repeat the second PET after therapy. Significant clinical 
improvements were noticed after EMDR as described in Table 1 for PTSD scales (PCLS, 
CAPS) and SUD scores (p < 0.001 for all scores). The second 18F-FDG PET was performed 
during the month in which the patient was declared in remission for PTSD. 
There was a positive correlation between the evolution of the SUD (T1  T0) and the PCLS (T1 
 T0), r = 0.74 and p < 0.001. The more disturbances decreased during the VRE, the higher the 
symptoms improved after EMDR therapy. 
The comparison between the patients assessed with 18F-FDG PET before and after EMDR 
therapy showed an increased metabolism in the bilateral precuneus with a right-predominance 
after treatment (p<0.005 uncorrected, k>180), as shown in Figure 2. No decreased metabolism 
was found. 
 
Relationship between clinical improvement after EMDR and precuneus metabolism 
There was a negative correlation between the difference in metabolic values (T1  T0) of the 
precuneus and the evolution of the CAPS (T1  T0), with r = -0.73 and p < 0.001. The higher 
the metabolic value of the precuneus increased after EMDR, the more the symptoms improved. 
There was a negative correlation between the metabolic value in the significant cluster 
precuneus before EMDR and the evolution of the PCLS (T1  T0), with r = -0.667 and p < 
0.006. The higher the precuneus metabolism before EMDR, the more the PCL-S scores 
decreased at the end of the therapy. The two correlations are depicted in Figure 3. 
No other correlation was found between the clinical scores and precuneus metabolism. 
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Discussion 
The objective of this study was to identify the regions of brain metabolism that evolve after 
EMDR therapy with symptomatic remission during stress exposure of a war scene in a group 
of military veterans suffering from PTSD. One of the most novel aspects is the use of PET 
imaging combined with VRE sensitization to measure brain metabolism during the interaction 
with the traumatic event. Therefore, this study highlights the exciting opportunity to use PET 
imaging to investigate brain metabolism during virtual exposure, and provides additional 
information on the pathophysiological response of EMDR therapy on PTSD. In comparison to 
fMRI, the competitive advantage of 18F-FDG brain PET imaging is to possibly capture an 
activation paradigm outside the acquisition scanner, during the radiopharmaceutical injection, 
and thus possibly develop complex paradigms involving for example VRE. In this line, this 
approach could be extended to other virtual environments or neuropsychological conditions. 
The SUD evolution correlated with the evolution of the PCLS. This validates that our virtual 
environment was effective in reactivating PTSD symptoms before therapy and that there was 
no fear response after EMDR. 
The precuneus was the sole brain structure with increased metabolism after symptom remission. 
This increased metabolism was correlated with symptom evolution as measured by the CAPS. 
The precuneus metabolism measured before therapy also predicted the clinical evolution after 
EMDR therapy. 
The precuneus is implied in autobiographical memory, multisensory integration and future-
oriented thinking (2). In a recent meta-analysis of non-VRE studies, it appears to be a key 
structure that regulates the fear network in fear conditioning and extinction protocol (11). Due 
to its functions, we can assume that the precuneus can modulate the subjective experience of 
anxious and fearful states to reprocess the traumatic memory and discharge it from its emotional 
load (11).  The memory is then perceived as a scene in which the patient is no longer involved 
instead of repeatedly reliving the memory. In other words, the subject becomes a neutral 
observer of the traumatic scene. 
The main limitation of this study is the low number of participants (n=15). Further experiments 
should reproduce our results with a wait-list group and go further by exploring the precise 
functions of the precuneus during EMDR therapy not only before and after therapy but also 
during the EMDR sessions. 
In conclusion, this study shows that precuneus metabolic improvement while reliving war 
combat correlates with a reduction in PTSD symptoms after EMDR therapy. Moreover, 
precuneus metabolism before therapy was a predictor of symptom evolution. Our results could 
suggest therapeutic implications leading to the use of rTMS or neurofeedback for modulating 
precuneus activity.   
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